Picture of Stryker logo

SYK Stryker Cashflow Statement

0.000.00%
us flag iconLast trade - 00:00
HealthcareConservativeLarge CapHigh Flyer

Annual cashflow statement for Stryker, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

2021
December 31st
2022
December 31st
2023
December 31st
2024
December 31st
2025
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:10-K10-K10-K10-KPRESS
Standards:
USG
USG
USG
USG
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line1,9942,3583,1652,9933,246
Depreciation
Amortisation
Deferred Taxes
Non-Cash Items8044352591,252
Unusual Items
Other Non-Cash Items
Changes in Working Capital-288-1,225-535-683605
Change in Accounts Receivable
Change in Inventories
Change in Accounts Payable
Change in Accrued Expenses
Change in Taxes Payable
Change in Other Liabilities
Net Change in Other Assets & Liabilities
Cash from Operating Activities3,2632,6243,7114,2425,044
Capital Expenditures-525-588-575-755-761
Purchase of Fixed Assets
Other Investing Cash Flow Items-334-2,336-387-2,245-4,105
Acquisition of Business
Sale/Maturity of Investment
Change in Net Investments
Purchase of Investments
Other Investing Cash Flow
Cash from Investing Activities-859-2,924-962-3,000-4,866
Financing Cash Flow Items-262-170-178-246-182
Other Financing Cash Flow
Total Cash Dividends Paid
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities-2,365-749-1,594-525113
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash1-1,1001,127681359